Drug class
Intravenous iron(III)-carbohydrate complex; parenteral iron replacement agent
Mechanism of action
A stable colloidal iron(III)-hydroxide complex with carboxymaltose carbohydrate. Following intravenous administration, iron is taken up by reticuloendothelial cells and made available for transferrin binding and incorporation into haemoglobin and iron stores; it is not a simple dissociating iron salt.
General use cases
- Treatment of iron-deficiency anaemia in adults and eligible paediatric patients when oral iron is ineffective, not tolerated or rapid iron replacement is needed
- Treatment of iron deficiency in selected patients with heart failure where the specific formulation is authorised; use and dosing are product-label specific
For general informational purposes only. Do not rely on, cross-reference, cite or use this information as evidence or support for legal, regulatory, commercial or other claims.
